Recently, Braxton et al. reported that FLT3 amplified cases display a high number of pathogenic variant when compared to FLT3 wild-type cases, suggesting that FLT3 amplification in mismatch repair proficient colorectal adenocarcinoma occurred as a late event [20]. This evidence concerns the gene FLT3 and colorectal adenocarcinoma.